Clario will now offer Strados' RESP™ Biosensor for the at-home capture of lung sounds.
Clario has announced a partnership with Strados Labs to provide the FDA-cleared RESP Biosensor for clinical trials. This wearable device is lightweight and non-invasive, with capabilities such as allowing for objective assessment of crackles, rhonchi, and wheeze events, as well as offering a streamlined approach for at-home cough monitoring in trial participants.
The wireless device records pulmonary sounds for 24 uninterrupted hours and has the capacity to hold up to 220 hours (about one and a half weeks) of recordings on board. With the capabilities of a digital stethoscope, this device can capture lung sounds, enabling measurement of cough frequency, cough severity, cough type (e.g., dry, productive), and other adventitious events (e.g., wheeze, rhonchi, crackles).
Clario and Strados Labs partner to bring new pulmonary endpoints to respiratory clinical trials. (2023, March 21). Cision PR Newswire.
Including Women of Childbearing Age in Clinical Research
March 26th 2024In recognition of International Women's Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and Marie Teil, Global Head of UCB’s Women of Childbearing Age Program. They speak about the specific challenges women with chronic illnesses face when accessing appropriate treatment and participating in clinical trials, UCB's Women of Childbearing Age Program and it’s most successful strategies, and much more.
Improving Engagement While Maintaining Data Integrity & Validity
March 19th 2024In recognition of Women's Health Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and uMotif's Chief Product Officer, Julia Lakeland, discuss new technologies improving patient engagement and reducing the emotional and logistical burdens of participation, ethical considerations that should be addressed when implementing those technologies, while ensuring patient privacy, and much more.